Consistent revenue growth from $1.7M in 2016 to $6.3M in 2023, demonstrating increasing financial capacity.
Significant asset growth from $10.2M in 2016 to $29.9M in 2023, indicating strong financial health and investment.
Low liability-to-asset ratio, with liabilities at $9.0M against assets of $29.9M in 2023, suggesting good financial management.
High percentage of expenses dedicated to programs (85%), indicating a strong focus on its core mission.
AI Transparency Report
Massachusetts Biomedical Initiatives is a science & technology nonprofit based in Worcester, Massachusetts, with reported revenue of $6.2M and assets of $31.3M. Our AI analysis assigns a Mission Score of 85/100 (Excellent). Approximately 85% of spending goes to programs, 10% to administration, and 5% to fundraising. Executive compensation is not explicitly detailed in the provided data, but the 0% compensation from related parties suggests a focus on mission rather than excessive insider payments. Revenue has grown +359% across 13 filing periods.